no body has access to the trail results... not until the data has been unblinded and analysed by a third party - not JnJ or OCC can’t possibly have access to the data
depending on the complexity of the trial it can take anywhere between 3 to 6 months after the data has been collated from the last patient
so the worst case scenario is OCC results may be delayed by Feb 2022 but I think it’s very unlikely - their trial is not that large
Ann: Proactive Investors Interview with Orthocells MD, page-26
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.5¢ |
Change
-0.020(2.92%) |
Mkt cap ! $159.0M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 67.0¢ | 65.0¢ | $245.7K | 371.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15000 | 65.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.5¢ | 12621 | 2 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |